Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease

Natural Bioactive Compounds in the Management of Type 2 Diabetes and Metabolic (Dysfunction)-Associated Steatotic Liver Disease

Type 2 diabetes (T2D) and metabolic (dysfunction)-associated steatotic liver disease (MASLD) affect a growing number of individuals worldwide. T2D and MASLD often coexist and substantially elevate the risk of adverse hepatic and cardiovascular clinical outcomes. Several common pathogenetic mechanism...

Full description

Saved in:
Bibliographic Details
Main Authors: Daniela Ciobârcă, Adriana Florinela Cătoi, Laura Gavrilaș, Roxana Banc, Doina Miere, Lorena Filip
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pharmaceuticals
Subjects:
type 2 diabetes
metabolic (dysfunction)-associated steatotic liver disease
non-alcoholic fatty liver disease
gut dysbiosis
natural bioactive compounds
berberine
Online Access:https://www.mdpi.com/1424-8247/18/2/279
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/2/279

Similar Items